dpx-survivac
Showing 1 - 8 of 8
Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory DLBCL Trial in Canada (DPX-Survivac, Pembrolizumab,
Active, not recruiting
- Adult Diffuse Large Cell Lymphoma
- +2 more
- DPX-Survivac
- +2 more
-
Calgary, Alberta, Canada
- +5 more
Nov 9, 2022
Breast Cancer Trial in Portland (biological, drug, radiation)
Recruiting
- Breast Cancer
- DPX-Survivac
- +3 more
-
Portland, OregonProvidence Portland Medical Center
Oct 19, 2021
DLBCL Trial in Ottawa, Toronto (DPX-Survivac, Cyclophosphamide)
Terminated
- Diffuse Large B-Cell Lymphoma
- DPX-Survivac
- Cyclophosphamide
-
Ottawa, Ontario, Canada
- +1 more
Jun 16, 2021
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Mineola, New York, Toronto (DPX-Survivac,
Completed
- Epithelial Ovarian Cancer
- +2 more
- DPX-Survivac
- +2 more
-
Mineola, New York
- +2 more
Jun 16, 2021
Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma Trial in Worldwide (DPX-Survivac,
Recruiting
- Relapsed Diffuse Large B-cell Lymphoma
- Refractory Diffuse Large B-cell Lymphoma
- DPX-Survivac
- +2 more
-
Fountain Valley, California
- +44 more
Jan 20, 2023
Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)
Active, not recruiting
- Ovarian Cancer
- +4 more
- DPX-Survivac
- +2 more
-
Tucson, Arizona
- +22 more
Mar 28, 2022
Recurrent Epithelial Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Peritoneal Cancer Trial in Canada, United States
Active, not recruiting
- Recurrent Epithelial Ovarian Cancer
- +2 more
- DPX-Survivac
- +2 more
-
Palo Alto, California
- +8 more
Jun 16, 2021
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Canada, United States (DPX-Survivac, low dose cyclophosphamide
Completed
- Ovarian Cancer
- +2 more
- DPX-Survivac
- low dose cyclophosphamide (oral)
-
Buffalo, New York
- +6 more
Apr 20, 2017